News|Articles|May 2, 2004

Pharmaceutical Technology

  • Pharmaceutical Technology-05-02-2004
  • Volume 28
  • Issue 5

aaiPharma Situation Underscores The Need for Due Diligence

Author(s)Jim Miller

Sponsors who have been lax in performing financial due diligence on their contractors have been given a wake-up call by the recent developments at aaiPharma.
External Link - article-94551.pdf

Articles in this issue

almost 22 years ago

Characterization of the Performance of Bin Blenders Part 1 of 3: Methodology

almost 22 years ago

An LC Method for the Separation and Determination of Ethynodiol Diacetate and Ethinyl Estradiol in Tablets

almost 22 years ago

In The Spotlight-May 2004

almost 22 years ago

FDA Eyes Manufacturing Innovation to Boost Drug Development

almost 22 years ago

Prepare for Bar Coding

almost 22 years ago

Validation and Compliance: Software Systems Prepare Manufacturers for Com(PAT)ibility

almost 22 years ago

Excipient Functionality

almost 22 years ago

Characterization of the Performance of Bin Blenders Part 1 of 3: Methodology

almost 22 years ago

May 2004

Newsletter

Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.

Subscribe Now!

Related Content